- 1 day ago
Pushing T cells down "memory lane" may improve cancer therapy
Scientists at St. Jude Children's Research Hospital identified proteins that help decide T cell fate and used the finding to improve...
- Oct 13, 2021
Researchers ‘extraordinarily optimistic’ about potential of CAR-T for pediatric brain cancer
Researchers hope to replicate the successes in pediatric acute lymphoblastic leukemia — among the most common pediatric cancers — by ...
- Jul 13, 2021
Immunotherapy Trial May Be Feasible to Combat Pediatric Pediatric Brain and Spinal Cord Tumors
An innovative clinical trial led by Dr. Nicholas Vitanza, a neuro-oncologist at Seattle Children’s, shows promise that delivering ...
- May 25, 2021
New insight into when CAR T is effective against childhood leukemia
Scientists and clinicians at UCL and Great Ormond Street Hospital (GOSH) studying the effectiveness of CAR T-cell therapies in children ...
- Apr 5, 2021
Study: Stem Cell Transplants Prevent Relapses of Most Common Childhood Cancer
Children and young adults who receive CAR T-cell therapy for the most common childhood cancer, acute lymphoblastic leukemia, suffer...
- Jan 26, 2021
Modified version of CAR T-cell therapy shows promise in targeting neuroblastoma
Now, a group of scientists at Children's Hospital Los Angeles have developed a modified version of CAR T that shows promise in targeting...
- Dec 2, 2020
Investigating Packaged CAR T-Cells For Early Childhood Eye Cancer
For some children with the rare eye cancer retinoblastoma, results from a study in mice suggest that a type of immunotherapy known as...
- Nov 30, 2020
New immunotherapy shows promise against rare childhood cancer
A novel CAR T-cell therapy developed by researchers at UCL and designed to target cancerous tumours, has shown promising early results ...
- Apr 1, 2020
Could a CAR-T Version 2.0 Be on the Way?
"A clinical trial will be the only way to truly answer whether this treatment will work in children with resistant disease, but the study...
- Dec 20, 2019
'What price life?' At a cost of hundreds of thousands a dose, novel cancer-killing drug spar
"The high-ticket price is part of a larger question. 'How much are we willing to pay to survive disease, and how much are governments...